This study investigates the ability of lymphocytes to utilize fatty acids originating from triacylglycerols and the effect of triacylglycerols upon mitogen-stimulated lymphocyte proliferation. Lymphocytes isolated from rat lymph nodes, spleen, thymus and lymphatic duct had a lipoprotein lipase activity of approx. 10 units/mg of protein, indicating that the fatty acids of circulating triacylglycerols are accessible to these cells. In culture, lymph node lymphocytes hydrolysed triacylglycerols added to the medium as emulsions. Both non-esterified fatty acids and free glycerol appeared in the cell culture medium, but their concentrations indicated that a high proportion of each (65- 
INTRODUCTION
Inflammatory and autoimmune disorders such as rheumatoid arthritis, systemic lupus erythematosus, psoriasis and multiple sclerosis are characterized by an overactive immune system which is directed against host tissues [1, 2] . Epidemiological studies indicate that the incidence of these disorders is low in regions where the dietary intake of vegetable or fish oils is high [3] [4] [5] . This has led to the suggestion that increasing the proportion of vegetable or fish oils in the diet could be of benefit to patients suffering from inflammatory diseases [3] [4] [5] . Indeed, such dietary manipulation has been reported to improve the clinical condition of patients suffering from rheumatoid arthritis [6, 7] , psoriasis [8] and multiple sclerosis [9, 10] . These oils are rich in the n-6 polyunsaturated fatty acids (PUFAs) linoleic acid (e.g. corn and sunflower oils) or y-linolenic acid (e.g. evening primrose oil), or in the n -3 PUFAs eicosapentaenoic and docosahexaenoic acids (fish oils). Despite their use in the clinical situation, the mechanism(s) by which PUFAs might affect the immune system is still not clear.
In vitro experiments show immunosuppressive effects of nonesterified unsaturated fatty acids, which may explain the apparent benefits of diets enriched in such fatty acids in inflammatory disorders. For example, a number of unsaturated fatty acids, including oleic (C18: 1,n-9), linoleic (C18 2,n-6), a-linolenic (C18 3,n-3), arachidonic (C20:4 n.6), eicosapentaenoic (C20: 5,n-3) and docosahexaenoic (C22: 6,n-3) acids, inhibit mitogen-stimulated proliferation of rat and human lymphocytes [1 1-13] and suppress production of interleukin-2, an immunoregulatory cytokine, by such cells [13, 14] . In addition, oleic, y-linolenic (C18:3,n-6) and eicosapentaenoic acids inhibit the natural killer cell activity of human lymphocytes [15, 16] . Although these findings indicate the potential mechanisms by which dietary lipids could suppress corporated into lymphocyte lipids in a time-dependent manner; linoleic acid was incorporated at a significantly greater rate than oleic acid. The majority of oleic acid (greater than 70%) was incorporated into cellular triacylglycerol, while less than 10% was incorporated into phospholipids. In contrast, linoleic acid incorporation into cellular triacylglycerol never exceeded 25 %, while up to 45 % was incorporated into phospholipids. Triacylglycerols containing polyunsaturated fatty acids inhibited concanavalin A-stimulated lymphocyte proliferation in a concentration-and time-dependent manner; triacylglycerols containing saturated fatty acids or oleic acid were not inhibitory. Such direct effects of certain triacylglycerols on lymphocyte function may explain why some clinical trials of polyunsaturated fatty acidrich diets have been successful in improving the condition of patients suffering from inflammatory diseases.
immune functions, caution must be exercised in extending the findings of in vitro studies to the in vivo situation. This is because fatty acids of dietary origin are transported in the bloodstream as triacylglycerols, rather than as non-esterified fatty acids, and little is known about the ability of lymphocytes to utilize triacylglycerol-fatty acids or about the effects of triacylglycerols on lymphocyte functions. Fatty acids are released from circulating triacylglycerols (present in chylomicrons and very-lowdensity lipoproteins) by the action of lipoprotein lipase (EC 3.1.1.34); however, the activity of this enzyme in lymphocytes is not known.
The present study investigated the ability of lymphocytes to utilize fatty acids present in triacylglycerols by (a) measuring the lipoprotein lipase activity of lymphocytes; (b) measuring the breakdown of various triacylglycerols by lymphocytes in culture; and (c) measuring the incorporation of radioactively labelled fatty acid from triacylglycerol into lymphocytes in culture. The potential ability of circulating triacylglycerols to cause immunosuppression was also studied by investigating the effect of a variety of triacylglycerols upon in vitro mitogen-stimulated lymphocyte proliferation. The triacylglycerols used in this study were trimyristroyl-, tripalmitoyl-, tristearoyl-, trioleoyl-, trilinoleoyl-, tri(cz)linolenoyl-and triarachidonoyl-glycerol. chemistry animal house and, unless otherwise indicated, were allowed ad libitum access to food and water.
The sources of chemicals, culture medium and medium supplements were as described previously [11, 17] . In addition, [1-_4C] Formation of trlacylglycerol emulsions for use In cell culture Triacylglycerol (7.5,umol) in a small volume of toluene was mixed with 0.4 mg of PC. After evaporation to dryness, 7.5 ml of Mg2+-and Ca2+-free PBS, pH 7.2, was added and the mixture was sonicated as described above. This gave a 1 mM stock solution of triacylglycerol which was further diluted with a sonicated mixture of PC in PBS to give solutions of lower concentration. These solutions were added to the cell culture medium to give the required triacylglycerol concentration (see the Results section for concentrations used).
Utilization of triacylglycerols by lymphocytes in vitro
Lymph node lymphocytes were cultured at 37°C in an air/CO2 (19:1) atmosphere at a density of 5 x 106 cells per well (final volume 2 ml) in 24-well plates in Hepes-buffered RPMI supplemented with 10 mM glucose, 2 mM glutamine, 10 % foetal calf serum, antibiotics (streptomycin and penicillin) and concanavalin A (ConA). The medium also contained emulsions of various triacylglycerols (final concentration 100 uM). After 48 h the medium was collected and the concentrations of triacylglycerol, and free glycerol and non-esterified fatty acid in the medium were determined by the assays of McGowan et al. [21] and Okabe et al. [22] respectively.
Incorporation of glycerol or of fatty acid from triacylglycerol by lymphocytes in vitro Lymph node lymphocytes were cultured as described above in medium containing 1 mM [U-_4C]glycerol (specific radioactivity 0.039 ,Ci/,umol) or an emulsion of 100 ,M tri[9,10-3H]oleoylglycerol (specific radioactivity 5.85 ,uCi/,umol) or 100 ,uM tri[1-14C]linoleoylglycerol (specific radioactivity 0.068 ,uCi/,umol).
After various times the cells were collected and washed three times with PBS. Lipid was extracted and analysed as described below.
Lipid extraction and analysis
Cells were resuspended in a small volume of PBS and sonicated (3 x 15 s at an amplitude of 12 ,um) in an MSE sonicator. Lipid was extracted using chloroform/methanol (2:1, v/v). Lipid classes were separated by t.l.c. on silica gel 60 plates using hexane/diethyl ether/acetic acid (70:30:2, by vol.). After t.l.c., lipids were detected by staining with iodine. The position of each 3H]oleoylglycerol and 0.4 mg of PC in 0.5 ml of benzene. After lipid class was determined by comparison with a commercially available standard lipid mixture which was separated on the same plate as the samples. Each identified spot was scraped from the t.l.c. plate and the lipid was extracted with chloroform/ methanol (2: 1, v/v). The lipid extract was transferred to scintillation counting vials, dried and the incorporation of radioactivity was determined by liquid scintillation counting.
Lymphocyte proliferation assay Lymph node lymphocytes were cultured as described above except that 5 x 105 cells per well (final volume 200 ul) and 96-well micro-titre plates were used. The medium contained emulsions formed with various triacylglycerols (see the Results section for concentrations used). After 24 h or 48 h, [6-3H] thymidine was added (0.2 ,uCi/well) and the cells were incubated for a further 18 h. The cells were then harvested on to glass fibre filters, washed and dried using a Skatron Cell Harvester. Incorporation of radioactivity was measured by liquid scintillation counting and was used to indicate lymphocyte proliferation [23] .
Other procedures Macrophages were removed from lymphocyte preparations by adherence to cell culture dishes, as described elsewhere [12] . Murine thioglycollate-elicited peritoneal macrophages were prepared and purified as described previously [17] . Glycerol kinase (EC 2.7.1.30) activity was determined by the method of Newsholme et al. [24] . Protein concentrations were measured by the method of Bradford [25] .
Data presentation and statistical analysis
Unless otherwise indicated, all data are expressed as means + S.E.M. for an indicated number of samples. Statistical significance was determined using the unpaired Student's t test. The lymphocyte preparations from lymph nodes, spleen and thymus contain a small proportion of macrophages (usually less than 5 %), and the macrophage is known to synthesize and secrete lipoprotein lipase [26] [27] [28] . In this study, the lipoprotein lipase activity of murine peritoneal macrophages was found to be 97.9 + 5.8 units/mg of protein (n = 3). Therefore it was possible that the lipoprotein lipase activity measured in the lymphocyte preparations could be due to the presence of contaminating macrophages. Lymphocytes collected by cannulation of the thoracic duct are completely devoid of phagocytic cells, including macrophages [18, 29] ; these lymphocytes contained a lipoprotein lipase activity similar to that of the other lymphocyte preparations (Table 1) . It is possible to remove contaminating macrophages from lymphocyte preparations using a variety of procedures, including adherence to the surface of cell culture dishes (see [18] UtIlIzatIon of triacylglycerols by lymphocytes in vitro Lymphocytes were cultured with various triacylglycerols (initial concentration 100 ,uM) and the concentrations of triacylglycerol, free glycerol and non-esterified fatty acids in the medium were measured after 48 h. The rate of triacylglycerol breakdown varied from approx. 8 to approx. 12 nmol/48 h for the various triacylglycerols (Table 2) . Interestingly, triacylglycerols containing PUFA were hydrolysed to a greater extent (approx. 30 %) than those containing saturated fatty acids or oleic acid. Nonesterified fatty acids and free glycerol appeared in the culture medium ( Table 2 ). The amount of non-esterified fatty acid which accumulated in the culture medium accounted for between 12 Incorporation of fatty acids from the triacylglycerols by lymphocytes in vitro Triacylglycerols added to the culture medium are hydrolysed by lymphocytes, with only a small increase in the concentration of non-esterified fatty acids in the medium ( Table 2 ), indicating that lymphocytes may be capable of utilizing triacylglycerol-derived fatty acids. This was studied by incubating lymphocytes with either trioleoylglycerol or trilinoleoylglycerol containing radioactivity labelled fatty acid. Oleic acid from triacylglycerol was incorporated into lymphocyte lipids (Table 3) . Incorporation of oleic acid into all lipid fractions increased with time in culture (Table 3) . At all three time points more than 70 % of the oleic acid incorporation was into cellular triacylglycerols, while incorporation into the phospholipid fraction never exceeded 10% of the total incorporation.
RESULTS
Linoleic acid from trilinoleoylglycerol was incorporated into lymphocyte lipids (Table 4 ). The rate of linoleic acid incorporation was much greater than that of oleic acid (see Table 3 ). This is consistent with the higher rate of hydrolysis of trilinoleoylglycerol reported in Table 2 , and the apparently greater uptake of released fatty acid ( Table 2 ). The incorporation of linoleic acid into lymphocyte lipids and into all lipid fractions increased with increasing time ofculture (Table 4) . Incorporation into cellular triacylglycerols never exceeded 400% of the total linoleic acid incorporation; incorporation of linoleic acid into the phospholipid fraction accounted for 25 % of the total incorporation at 18 h and almost 45 % at 64 h ( Table 4) .
Incorporation of glycerol by lymphocytes in vitro
The increase in the glycerol concentration in the medium when lymphocytes were cultured with emulsions containing triacyl- (Table 5) . At a concentration of 100 ,uM, such triacylglycerols inhibited lymphocyte proliferation by up to 85 %.
The effect of triacylglycerols on lymphocyte proliferation was also investigated at an earlier period in culture (Table 6 ); in all cases the triacylglycerol concentration was 100 1sM and thymidine incorporation was measured over the final 18 h of the culture period. At the earlier time point (42 h) the triacylglycerols containing PUFAs inhibited proliferation (by up to 80 %), but triacylglycerols containing other fatty acids had no effect (Table  6 ). glycerols did not account for all of the triacylglycerol glycerol that should have been released calculated from the decrease in triacylglycerol concentration (Table 2) . This suggests that lymphocytes may be capable of utilizing glycerol. This was studied by incubating lymphocytes with radioactively labelled glycerol.
Glycerol from the culture medium was incorporated into lymphocyte lipids (Figure 1 ). This confirms that lymphocytes are able to utilize free glycerol. Such utilization would require the presence of glycerol kinase, the enzyme responsible for the conversion of glycerol to glycerol 3-phosphate prior to triacylglycerol and phospholipid synthesis [30] . Indeed, rat lymph node lymphocytes possess a glycerol kinase activity of 0.6 + 0.1 nmol of glycerol phosphorylated/min per mg of protein (n = 3), which is about 10 % of the activity measured in rat liver [24] . This activity of glycerol kinase could account for the glycerol incorporation by lymphocytes (Figure 1 ).
The effect of trlacylglycerols on in vitro lymphocyte proliferation
The effect of different concentrations of a number of triacylglycerols upon ConA-stimulated lymphocyte proliferation was investigated (Table 5) ; in all cases the total concentration of emulsion was kept constant and thymidine incorporation was DISCUSSION This study investigates, for the first time, triacylglycerol metabolism by lymphocytes. In addition, the effect of triacylglycerols on a key immune function, lymphocyte proliferation, was examined in vitro.
Using a standard assay [20] , lymphocytes isolated from lymph nodes, spleen and thymus were shown to contain the enzyme lipoprotein lipase, which had an activity of approx. 10 units/mg of cellular protein (Table 1 ). This enzyme is responsible for the hydrolysis of circulating triacylglycerols in specific tissues so that released fatty acids are taken up by the cells of that tissue. The activity of lipoprotein lipase is high in adipose tissue, heart and red skeletal muscle [31] ; lower activities are reported in other tissues such as liver, kidney, lung and spleen [32, 33] . The enzyme is synthesized by a variety ofcells including adipocytes, myocytes, epithelial cells and skeletal and smooth muscle cells [34, 35] . These cells release the lipase which then becomes attached to local endothelial cells via heparan sulphate proteoglycans [31, 36] . This locates the enzyme on the luminal surface of the endothelial cells in the tissue in which it is synthesized. Hence it catalyses the hydrolysis of triacylglycerols in circulating lipoproteins.
Macrophages and monocytes synthesize large amounts of lipoprotein lipase [26] [27] [28] 37] , much of which is secreted into the medium when the cells are in culture [26] [27] [28] 37] . The activity of the enzyme in murine peritoneal macrophages has not been previously reported; it was found to be approximately 100 units/mg cellular protein. This activity is in general agreement with previous reports for the activity in human peripheral blood monocytes [28] , rabbit alveolar macrophages [37] and a macrophage-like cell line [37] . It has been shown that, in addition to secreting lipoprotein lipase into the culture medium, macrophages also attach the enzyme to the outer surface of their plasma membrane [38] . It is not known whether the lipoprotein lipase oflymphocytes detected in the present study is intracellular, and destined for secretion, or whether it is bound to the cell surface.
Since the lipoprotein lipase activity of macrophages is high, the enzyme activity detected in lymphocyte preparations could have been due to a small proportion of macrophages. However, thoracic duct lymphocytes, which are devoid of macrophages [18, 29] , and lymph node lymphocytes depleted of macrophages, exhibited lipoprotein lipase activities similar to those of the tissue lymphocyte preparations.
Consistent with the apparent ability of lymphocytes to produce lipoprotein lipase, triacylglycerols added to lymphocyte culture media were hydrolysed (Table 2) . However, the proportion of triacylglycerol degraded was less than 10%, suggesting that only a small amount of the enzyme is secreted by these cells. Indeed, the activity of lipoprotein lipase in the culture medium of lymphocytes which had been cultured for 48 h was only 5-10 % of the cellular activity (results not shown). This is in contrast to the situation found with macrophages, where the lipoprotein lipase activity of the culture medium can exceed that of the cells within 2 h of the onset of culture, and can ultimately be 10 or 20 times greater than the cellular activity [28] .
Triacylglycerols containing PUFAs were hydrolysed to a greater extent than those containing saturated fatty acids or oleic acid (Table 2 ). This suggests that the lymphocyte lipoprotein lipase has the ability to differentiate between substrates, possibly on the basis of both fatty acid chain length and degree of unsaturation. Although there are reports that lipoprotein lipase does not exhibit specificity with respect to the acyl chains of its substrate [39, 40] , the finding of greater hydrolysis of triacylglycerols containing PUFAs than of those containing saturated fatty acids is in accordance with a previous study of the substrate specificity of the enzyme from human milk [41] . That study showed that triacylglycerols containing linoleic or linolenic acids are hydrolysed at a rate up to four times greater than the rate of hydrolysis of triacylglycerols containing saturated fatty acids (myristic, palmitic or stearic acids) [41] . However, this earlier study found that triacylglycerol was the most rapidly hydrolysed triacylglycerol of those tested [41] ; in the current study trioleoylglycerol was hydrolysed at a rate comparable with that of hydrolysis of triacylglycerols containing saturated fatty acids (Table 2) .
Since it is unlikely that physiologically available triacylglycerols will be composed of three identical fatty acids, it would be of interest to investigate the ability of lymphocyte lipoprotein lipase to hydrolyse triacylglycerols containing fatty acids of more than one type. However, lipoprotein lipase also exhibits specificity with respect to the position of fatty acid chains in the triacylglycerol, with the ester bond at position 1 being attacked in preference to that at position 2 [41] ; this could make the interpretation of studies comparing rates ofhydrolysis of 'mixed' triacylglycerols difficult.
Not all ofthe triacylglycerol that was hydrolysed in lymphocyte culture medium could be accounted for by the appearance of free glycerol and fatty acids ( Table 2 ), suggesting that the cells are capable of utilizing both products of triacylglycerol hydrolysis. Indeed, lymphocytes were capable of incorporating glycerol ( Figure 1 ) and fatty acid derived from triacylglycerols (Tables 3  and 4 ) from the medium into cellular lipids. Between 70 and 90 % of the fatty acid released from triacylglycerols was utilized by lymphocytes (Table 2) , and, based upon the experiments with radioactively labelled triacylglycerol-fatty acids, most (more than 95 %) of the utilized fatty acid was incorporated into lymphocyte lipids. The rate of incorporation of triacylglycerol-fatty acid differed between the two triacylglycerols tested. The rate of oleic acid incorporation from trioleoylglycerol was lower than that of linoleic acid from trilinoleoylglycerol, and also that of nonesterified fatty acids in similar culture conditions (200-400 nmol/mg of protein per 64 h [42] ). The rate of linoleic acid incorporation from trilinoleoylglycerol was similar to that of non-esterified fatty acids added to the culture medium [42] . The intracellular fate of triacylglycerol-fatty acids differed according to their origin. Most (more than 70 %) triacylglycerol-oleic acid was incorporated into cellular triacylglycerol, with only a small proportion (less than 10 %) being incorporated into the phospholipid fraction (Table 3 ). In contrast, up to 45 % of triacylglycerol-linoleic acid was incorporated into phospholipids with less than 40% being incorporated into cellular triacylglycerols (Table 4) . In this respect, the fate of linoleic acid incorporated from triacylglycerol resembles the incorporation of non-esterified fatty acids [42] . A greater proportion (40-65 %, depending upon the fatty acid) of non-esterified fatty acid taken up by lymphocytes is incorporated into phospholipids than in cellular triacylglycerols (20-45 %, depending upon the fatty acid) [42] . This indicates not only that the ability of lymphocytes to utilize different triacylglycerol-fatty acids is different, but also that the intracellular handling of fatty acids may differ according to their origin. The mechanism underlying this difference is not known.
In contrast to a lipoprotein lipase-mediated mechanism for uptake of the components of triacylglycerols, an alternative mechanism could be uptake of entire triacylglycerols, as has been shown to occur with fibroblasts in culture [43] . However, the experimental data do not support this mechanism, in that trioleoylglycerol and trilinoleoylglycerol were utilized by lymphocytes at significantly different rates and had different fates (Tables 3 and 4) . If entire triacylglycerols were taken by a non-specific mechanism, then the rates of uptake of both triacylglycerols should be the same and the major intracellular fate would be triacylglycerol. However, much of the trilinoleoylglycerol is incorporated into phospholipid, even after only 18 h of culture.
The findings of this study are important in relation to the use of dietary lipid manipulation as an immunosuppressive therapy in inflammatory diseases. Many studies have shown immunosuppressive effects of non-esterified unsaturated fatty acids in vitro (see the Introduction). It is often assumed that these effects are due to eicosanoids synthesized from the unsaturated fatty acids. However, it has been shown that such immunosuppressive effects occur even when eicosanoid synthesis is inhibited [12] . It seems likely that the effects of fatty acids are due to their incorporation into membrane phospholipids, altering the fatty acid composition and fluidity [42] . In other tissues and cell types such changes have been shown to affect receptor activity (see [44] ) and signal transduction mechanisms (see [45, 46] (Tables 5 and 6 ). Such an effect has not been previously reported. Recently other effects of PUFA-containing triacylglycerols upon in vitro lymphocyte functions have been described. For example, it has been shown that trieicosapentaenoylglycerol inhibits the antigen-presenting function of murine spleen cells [47] and that both trieicosapentaenoylglycerol and tridocosahexaenoylglyerol inhibit the natural killer cell activity of human peripheral blood lymphocytes [48] . Such direct immunosuppressive effects of triacylglycerols may explain why, in some clinical trials, PUFA-rich diets have been successful in improving the clinical condition of patients suffering from inflammatory diseases. P. Y. holds a SERC Training Award. We thank Mr. Peter Fisher for his assistance with trilinoleoylglycerol synthesis.
